Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-24 @ 1:33 PM
NCT ID:
NCT00117195
Eligibility Criteria:
Inclusion Criteria:
As a participant with PD or PS:
* Age \>21
* Clinical diagnosis of PD or PS (at least two of the three cardinal symptoms: resting tremor, rigidity, bradykinesia) and a clinical response to dopaminergic therapy
For Healthy Control:
* Age \>21
Exclusion Criteria:
As a participant with PD or PS:
* Any other concomitant neurologic condition likely to interfere with handwriting, use of the computer, or other motor tasks tested in this study (e.g. stroke, demyelinating disease, visual loss)
For Healthy Control:
* Any indication of parkinsonism on examination
* Any other concomitant neurologic condition likely to interfere with handwriting, use of the computer, or other motor tasks (e.g. stroke, demyelinating disease, visual loss)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
22 Years
Study:
NCT00117195
Study Brief:
Protocol Section:
NCT00117195